General and acute paediatrics
Short report
Bronchoconstriction following nebulised colistin in cystic
fibrosis
S Cunninghama, A Prasada, L Collyerb, S Carrb, I Balfour Lynnc, C Wallisa
a Portex
Anaesthesia, Intensive Care and Respiratory Medicine, Great Ormond
Street Hospital for Children, Great Ormond Street, London WC1N
3JH, UK, b Barts & The London NHS Trust, Whitechapel,
London E1 1BB, UK, c Royal Brompton & Harefield NHS Trust, Sydney
Street, London SW3 6NP, UK
Correspondence to: Dr Cunningham steve.cunningham{at}talk21.com
Accepted 16 November
2000
Nebulised colistin is regularly used as antipseudomonal therapy
in children with cystic fibrosis. We assessed bronchoconstriction in
response to nebulised colistin in 58 children. Nebulised colistin significantly reduced FEV1, MEF25%, and
SaO2 for 15 minutes. In 20 children the
reduction was greater than 10% from baseline FEV1, and was
still at that level in five at 30 minutes. Subjective assessment,
baseline FEV1, and serum IgE were unable to identify susceptible children. It is recommended that children receiving colistin should be carefully assessed for bronchoconstriction.
Keywords: cystic fibrosis; colistin; bronchoconstriction
© 2001 by Archives of Disease in Childhood
Relevant Article
- An evidence and consensus based guideline for acute diarrhoea management
- K Armon, T Stephenson, R MacFaul, P Eccleston, U Werneke, and HARRY BAUMER
Arch. Dis. Child. 2001 85: 132-142.[Abstract] [Full Text] [PDF]
This article has been cited by other articles:
-
Lee, T.
(2009). Eradication of early Pseudomonas infection in cystic fibrosis. Chronic Respiratory Disease
6: 99-107
[Abstract] -
Wallace, S. J., Li, J., Rayner, Craig. R., Coulthard, K., Nation, R. L.
(2008). Stability of Colistin Methanesulfonate in Pharmaceutical Products and Solutions for Administration to Patients. Antimicrob. Agents Chemother.
52: 3047-3051
[Abstract] [Full Text] -
Landman, D., Georgescu, C., Martin, D. A., Quale, J.
(2008). Polymyxins Revisited. Clin. Microbiol. Rev.
21: 449-465
[Abstract] [Full Text] -
Falagas, M. E., Kasiakou, S. K., Tsiodras, S., Michalopoulos, A.
(2006). The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.. Clin Med Res
4: 138-146
[Abstract] [Full Text] -
Alothman, G. A., Ho, B., Alsaadi, M. M., Ho, S. L., O'Drowsky, L., Louca, E., Coates, A. L.
(2005). Bronchial Constriction and Inhaled Colistin in Cystic Fibrosis. Chest
127: 522-529
[Abstract] [Full Text] -
Berlana, D., Llop, J. M., Fort, E., Badia, M. B., Jodar, R.
(2005). Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health Syst Pharm
62: 39-47
[Abstract] [Full Text] -
Conway, S P
(2005). Nebulized antibiotic therapy: the evidence. Chronic Respiratory Disease
2: 35-41
[Abstract] -
Gibson, R. L., Burns, J. L., Ramsey, B. W.
(2003). Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
168: 918-951
[Abstract] [Full Text] -
Byrne, N M, Keavey, P M, Perry, J D, Gould, F K, Spencer, D A
(2003). Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Arch. Dis. Child.
88: 715-718
[Abstract] [Full Text]
eLetters:
Read all eLetters
- Nebulised Colistin in Cystic Fibrosis
- Jayesh Bhatt
- ADC Online, 30 May 2001 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



